A dosimetric comparison of 169Yb versus 192Ir for HDR prostate brachytherapy

Medical Physics

Volumn 32, Issue 12, 2005, Pages 3832-3842

  Lymperopoulou, G ^a   Papagiannis, P ^a   Sakelliou, L ^a   Milickovic, N ^b   Giannouli, S ^c   Baltas, D ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Klinikum Offenbach GmbH   (Germany)

^c Pi Medical Ltd   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DOSIMETRY; MONTE CARLO METHODS; MULTIOBJECTIVE OPTIMIZATION; ONCOLOGY; QUALITY CONTROL; RADIOTHERAPY;

COMPREHENSIVE ANALYSIS; DOSE-VOLUME HISTOGRAMS; HDR BRACHYTHERAPY; HIGH-DOSE-RATE BRACHYTHERAPY; INVERSE TREATMENT; PROSTATE BRACHYTHERAPY; PROSTATE IMPLANTS; TREATMENT PLANNING SYSTEMS;

UROLOGY;

IRIDIUM 192; RADIOISOTOPE; UNCLASSIFIED DRUG; YTTERBIUM; YTTERBIUM 169; IRIDIUM;

ARTICLE; BRACHYTHERAPY; CASE REPORT; DOSIMETRY; ENERGY; HISTOGRAM; HUMAN; IMPLANT; MALE; MONTE CARLO METHOD; PHOTON THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; TREATMENT PLANNING; BIOPHYSICS; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER SIMULATION; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; STATISTICS;

BIOPHYSICS; BRACHYTHERAPY; COMPUTER SIMULATION; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MONTE CARLO METHOD; PROSTATIC NEOPLASMS; RADIOISOTOPES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; YTTERBIUM;

EID: 33644999532     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2126821     Document Type: Article

References (37)

1. D. L. D. Mason, J. J. Battista, R. B. Barnett, and A. T. Porter, " Ytterbium-169: Calculated physical properties of a new radiation source for brachytherapy, " Med. Phys. 19, 695-703 (1992).
2. M. S. MacPherson and J. J. Battista, " Dose distributions and dose rate constants for new ytterbium-169 brachytherapy seeds, " Med. Phys. 22, 89-96 (1995).
3. 169Yb seed model X1267, " Phys. Med. Biol. 40, 1317-1330 (1995).
4. H. Perera, J. F. Williamson, Z. Li, V. Mishra, and A. S. Meigooni, " Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new ytterbium-169 brachytherapy source, " Int. J. Radiat. Oncol., Biol., Phys. 28, 953-970 (1994).
5. P. K. Das, V. Mishra, H. Perera, A. S. Meigooni, and J. F. Williamson, " A secondary air kerma strength standard for Yb-169 interstitial brachytherapy sources, " Phys. Med. Biol. 40, 741-756 (1995).
6. B. Fisher, A. Porter, R. Barnett, D. Mason, E. Papiez, and J. Battista, " First clinical application of a new brachytherapy source - Ytterbium-169, " Endocur. Hypertherm. Oncol. 9, 195-199 (1993).
7. S. M. Loft, I. P. Coles, and R. G. Dale, " The potential of ytterbium 169 in brachytherapy: a brief physical and radiobiological assessment, " Br. J. Radiol. 65, 252-257 (1992).
8. 169Yb data, " Int. J. Appl. Radiat. Isot. 56, 181-188 (2002).
9. 169Yb and comparison with its reactor-based generation, " Int. J. Appl. Radiat. Isot. 63, 235-239 (2005).
10. N. S. Patel, P. Fan, S. T. Chiu-Tsao, K. Ravi, W. Sherman, H. Quon, J. Pisch, H. S. Tsao, and L. B. Harrison, " Ytterbium-169: A promising new radionuclide for intravascular brachytherapy, " Cardiovasc. Radiat. Med. 2, 173-180 (2001).
11. G. Kovács, R. Pötter, T. Loch, J. Hammer, I. K. Kolkman-Deurloo, J. J. M. C. H. de la Rosette, H. Bertermann, " GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer, " Radiother. Oncol. 74, 137-148 (2005).
12. D. J. Demanes, R. R. Rodriguez, L. Schour, D. Brandt, and G. Altieri, " High-Dose-Rate Intensity-Modulated Brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results, " Int. J. Radiat. Oncol., Biol., Phys. 61, 1306-1316 (2005).
13. R. M. Galalae et al., " Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer, " Int. J. Radiat. Oncol., Biol., Phys. 58, 1048-1055 (2004).
14. A. Martinez, R. Galalae, G. J. Razvan, C. Mitchell, G. Gustafson, and G. Kovacs, " No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose, " J. Urol. (Paris), 170, 2296-2301 (2003).
15. A. C. A. Pellizzon, W. Nadalin, J. V. Salvajoli, R. C. Fogaroli, P. E. Novaes, M. A. C. Maia, and R. Ferrigno, " Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer, " Radiother. Oncol. 66, 167-172 (2003).
16. T. Martin, S. Roeddiger, R. Kureka, T. Dannenberg, O. Eckart, C. Kolotas, R. Heyd, B. Rogge, D. Baltas, U. Tunn, and N. Zamboglou, " 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer, " Radiother. Oncol. 71, 35-41 (2004).
17. T. Martin, C. Kolotas, T. Dannenberg, G. Strassmann, H. G. Vogt, R. Heyd, B. Rogge, D. Baltas, R. Kurek, U. Tunn, and N. Zamboglou, " New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation, " Radiother. Oncol. 52, 257-260 (1999).
18. T. Martin, D. Baltas, R. Kurek, S. Röddiger, M. Kontova, G. Anagnostopoulos, T. Dannenberg, T. Buhleier, and G. Skazikis, " 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study, " Strahlenther. Onkol. 180, 225-232 (2004).
19. Y. Yoshioka, T. Nose, K. Yoshida, R.-J. OH, Y. Yamada, E. Tanaka, H. Yamazaki, T. Inoue, and T. Inoue, " High-Dose-Rate Brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity, " Int. J. Radiat. Oncol., Biol., Phys. 56, 213-220 (2003).
20. G. Gustafson, D. Demanes, R. Rodriguez, C. Mitchell, R. Ravanera, G. Edmundson and A. Martinez, " HDR monotherapy for early stage prostate cancer: Toxicity results utilizing the Common Toxicity Criteria, " Int. J. Radiat. Oncol., Biol., Phys. 57, Suppl, Ab. 176, 230-231 (2003).
21. R.R. Rodriguez, D.J. Demanes, G. Altieri, California Endocurietherapy Cancer Centers HDR monotherapy program for prostate cancer: Early results. Abstract and Slide Compendium of the 11th International Brachytherapy Meeting, Santa Fe (2002).
22. A. A. Martinez, I. Pataki, G. Edmundson, E. Sebastian, D. Brabbins, and G. Gustafson, " Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favourable stage prostate cancer: a feasibility report, " Int. J. Radiat. Oncol., Biol., Phys. 49, 61-69 (2001).
23. G. M. Daskalov, E. Loeffler, and J. F. Williamson, " Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source, " Med. Phys. 25, 2200-2208 (1998).
24. D. Baltas, C. Kolotas, K. Geramani, R. Mould, G. Ioannidis, M. Kekchidi, and N. Zamboglou, " A conformal Index (COIN) to evaluate implant quality and dose specification in brachytherapy, " Int. J. Radiat. Oncol., Biol., Phys., 40, 515-524 (1988).
25. N. Milickovic, M. Lahanas, M. Papagiannopoulou, N. Zamboglou and D. Baltas, " Multiobjective anatomy-based dose optimization for HDR-brachytherapy with constraint free deterministic algorithms, " Phys. Med. Biol. 47, 2263-80 (2002).
26. TM - A General Monte Carlo N -Particle Transport Code: Version 4C, " Report LA-13709-M, Los Alamos, NM: Los Alamos National Laboratory, 2000.
27. Nuclear Data Database (NUDAT). Available online by the Nuclear Energy Agency (NEA) at http://db.nea.fr
28. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group 43, " Med. Phys. 22, 209-234 (1995).
29. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations, " Med. Phys. 31, 633-674 (2004).
30. A. Angelopoulos, P. Baras, L. Sakelliou, P. Karaiskos, and P. Sandilos, " Monte Carlo dosimetry of a new 192Ir high dose rate brachytherapy source, " Med. Phys. 27, 2521-2527 (2000).
31. M. Lahanas, D. Baltas, and N. Zamboglou, " A hybrid evolutionary multiobjective algorithm for anatomy based dose optimization algorithm in HDR brachytherapy, " Phys. Med. Biol. 48, 399-415 (2003).
32. M. Lahanas, D. Baltas, S. Giannouli, and N. Zamboglou, " Global convergence analysis of fast multiobjective gradient based dose optimization algorithms for high dose rate brachytherapy, " Phys. Med. Biol. 48, 599-617 (2003).
33. N. Milickovic, M. Lahanas, D. Baltas, and N. Zamboglou, " Comparison of evolutionary and deterministic multiobjective algorithms for dose optimization in brachytherapy, " in Proceedings of the 1st International Conference, EMO 2001, Zurich, Switzerland, Lecture Notes in Computer Science, edited by, E. Zitzler, K. Deb, L. Thiele, C. Coello Coello, and, D. Corne, (Springer-Verlag, Berlin, 2001, Vol. 1993, pp. 167-180.
34. M. Lahanas, D. Baltas, and N. Zamboglou, " Anatomy-based three dimensional dose optimization in brachytherapy using multiobjective genetic algorithms, " Med. Phys. 26, 1904-1918 (1999).
35. 192Ir sources, " Med. Phys. 26, 2441-2444 (1999).
36. L. L. Anderson, " A "natural" volume-dose histogram for brachytherapy, " Med. Phys. 13 898-903 (1986).
37. L.L. Anderson, " Dose specification and quantification of implant quality, " in Brachytherapy Physics edited by, J. F. Williamson, B. R. Thomadsen, and, R. Nath, (American Medical Physics, Madison, WI, 1995) pp. 343-360.